ACMSD
Basic information
Region (hg38): 2:134838616-134902034
Links
Phenotypes
GenCC
Source:
- epilepsy (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (46 variants)
- not_provided (5 variants)
- ACMSD-related_disorder (3 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACMSD gene is commonly pathogenic or not. These statistics are base on transcript: NM_000138326.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 46 | 47 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
Total | 0 | 0 | 47 | 4 | 1 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACMSD | protein_coding | protein_coding | ENST00000356140 | 10 | 63488 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.39e-8 | 0.596 | 125694 | 0 | 53 | 125747 | 0.000211 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0105 | 191 | 191 | 0.998 | 0.0000103 | 2225 |
Missense in Polyphen | 77 | 74.137 | 1.0386 | 837 | ||
Synonymous | -0.618 | 79 | 72.3 | 1.09 | 0.00000464 | 618 |
Loss of Function | 1.16 | 15 | 20.7 | 0.725 | 0.00000106 | 230 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000809 | 0.000802 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000601 | 0.000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000116 | 0.000114 |
Middle Eastern | 0.000601 | 0.000544 |
South Asian | 0.000296 | 0.000294 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Converts alpha-amino-beta-carboxymuconate-epsilon- semialdehyde (ACMS) to alpha-aminomuconate semialdehyde (AMS). ACMS can be converted non-enzymatically to quinolate (QA), a key precursor of NAD, and a potent endogenous excitotoxin of neuronal cells which is implicated in the pathogenesis of various neurodegenerative disorders. In the presence of ACMSD, ACMS is converted to AMS, a benign catabolite. ACMSD ultimately controls the metabolic fate of tryptophan catabolism along the kynurenine pathway. {ECO:0000269|PubMed:19843166}.;
- Pathway
- Tryptophan metabolism - Homo sapiens (human);Tryptophan Metabolism;NAD+ biosynthetic pathways;Tryptophan metabolism;Tryptophan catabolism;Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism;Metabolism of amino acids and derivatives;2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA;Metabolism;L-kynurenine degradation;Tryptophan metabolism;Tryptophan degradation;superpathway of tryptophan utilization;tryptophan degradation
(Consensus)
Recessive Scores
- pRec
- 0.128
Intolerance Scores
- loftool
- 0.344
- rvis_EVS
- -0.4
- rvis_percentile_EVS
- 26.53
Haploinsufficiency Scores
- pHI
- 0.162
- hipred
- N
- hipred_score
- 0.436
- ghis
- 0.441
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.994
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Acmsd
- Phenotype
Gene ontology
- Biological process
- tryptophan catabolic process;secondary metabolic process;protein complex oligomerization;negative regulation of quinolinate biosynthetic process;picolinic acid biosynthetic process;regulation of 'de novo' NAD biosynthetic process from tryptophan
- Cellular component
- cytoplasm;cytosol
- Molecular function
- aminocarboxymuconate-semialdehyde decarboxylase activity;protein binding;zinc ion binding;hydrolase activity